BBDC4 gained 6% on the week to BRL 16.99, outpacing most of its Brazilian banking peers — yet the insider register tells a quietly different story about where those close to the bank see fair value.
The most telling signal this week comes from the executive suite. Bradesco's board-level sellers have been consistent. The Executive Board group recorded multiple sales in early July at prices around BRL 18.25–18.36, and a Head of Division sold again on August 25 at BRL 16.61. The net 90-day insider position is a modest positive in share terms — roughly 344,500 shares net bought — but the value of recent disclosed sales still skews toward distribution rather than accumulation. The trades carry low significance scores individually, but the pattern of selling into rallies, from around BRL 18 in July down to BRL 16.61 this week, is consistent with insiders treating price strength as an exit rather than a re-entry point.
The lending market offers no real tension to write about here, and that is itself useful context. Availability is essentially uncapped — the borrow pool is nearly untouched, with utilization rounding to zero across almost every session this month. Cost to borrow is just 0.51%, close to the floor of its recent range, and the 52-week peak utilization was only 13.4%. This is not a stock where the short-selling community is pressing hard. The ORTEX short score confirms it: the reading dropped sharply from around 36 in late July to 25.2 now, placing Bradesco in the 95th percentile by short-score rank — meaning short-side pressure is lower than nearly all peers. Days-to-cover ranks in the 98th percentile, reinforcing how thin the short book actually is.
The Street angle is limited by stale data — available analyst price targets are more than a year old and cannot be responsibly quoted here. What the valuation multiples do show is a stock that remains cheap on an absolute basis: price-to-earnings near 5.8x and price-to-book under 1.0x. Both multiples have compressed over the past 30 days as the stock dropped around 8% on the month before this week's bounce. The dividend score ranks in the 84th percentile across the ORTEX universe, suggesting the yield profile is still a meaningful part of the bull case — though the most recent corporate action recorded was a rights issue in August rather than a fresh cash dividend. EPS momentum scores are unremarkable, sitting near the 50th percentile on both 30- and 90-day horizons, and the earnings surprise rank is similarly median. Growth expectations have improved — a prior note flagged forward EPS year-on-year growth climbing above 20% — but the momentum picture has not yet caught up.
On earnings, the recent track record is worth noting plainly. The last three reported quarters each produced a negative first-day move: down 2.9%, 3.5%, and 4.1% respectively on the day of results. Five-day moves were consistently worse, ranging from -7.4% to -8.1%. The next earnings event is scheduled for November 4. That pattern of post-results selling does not tell you what happens next time, but it does suggest the stock has repeatedly struggled to sustain moves through the reporting window.
Among peers this week, BBAS3 led the Brazilian bank cohort with a gain of nearly 8%, while ITUB4 and ITSA4 added 2.8% and 4.2% respectively. Bradesco's 6% weekly gain therefore sits in the middle of the pack rather than at the top — a partial recovery from a weaker month rather than a breakout. The stock remains roughly 8% lower than where the Executive Board was selling in early July. The key question heading toward November is whether the earnings trajectory has shifted enough to break the pattern of results-day weakness.
See the live data behind this article on ORTEX.
Open BBDC4 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
